Cesca Therapeutics Inc (NASDAQ:KOOL), shows bullish price action with up move on a 10x surge in volume. It represents a successful retest of the January 21 breakout when prices popped 111% on massive turnover of 32.9M shares after the company announced positive Phase 1b clinical trial results for its stem cell therapy for critical limb ischemia.The company acquired development partner TotipotentRX shortly thereafter and changed its name from Thermogenesis.Last month, it submitted a pre-IDE information package to the FDA for the product, now called SurgWerks, as the first step in its commercialization efforts in the U.S.Considering its microscopic market cap of $66M, retail investors should insist on thorough due diligence before considering deploying capital. Cesca Therapeutics Inc (NASDAQ:KOOL), shares after opening at $1.80 moved to $2.19 on last trade day and at the end of the day closed at $2.06. Company price to sales ratio in past twelve months was calculated as 3.91 and price to cash ratio as 29.22. Cesca Therapeutics Inc (NASDAQ:KOOL), showed a positive weekly performance of 45.07%.
Galena Biopharma Inc (NASDAQ:GALE), was the recipient of a significant growth in short interest in January. As of March 31st, there was short interest totalling 25,709,429 shares, a growth of 8.1% from the March 14th total of 23,773,708 shares, StockRatingsNetwork reports. Approximately 21.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 6,478,089 shares, the days-to-cover ratio is presently 4.0 days. Galena Biopharma Inc (NASDAQ:GALE), shares fell 0.44% in last trading session and ended the day on $2.28. Galena Biopharma Inc (NASDAQ:GALE),return on equity ratio is recorded as -435.40% and its return on assets is -113.60%. Galena Biopharma Inc (NASDAQ:GALE), yearly performance is -7.32%.
On April 24, 2014, Sequans Communications SA ADR (NYSE:SQNS), announced financial results for the first quarter ended March 31, 2014. Sequans Communications SA ADR (NYSE:SQNS), shares moved down 18.22% in last trading session and was closed at $2.02, while trading in range of $ 1.95 – 2.29. Sequans Communications SA ADR (NYSE:SQNS), year to date (YTD) performance is 1.00%.
On April 4, 2014, Ocean Power Technologies Inc (NASDAQ:OPTT), announced the pricing of an underwritten public offering of 3,800,000 shares of its common stock at a price of $3.10 per share. The company has also granted to the underwriters a 30-day option to acquire an additional 570,000 shares to cover overallotments in connection with the offering. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $10.8 million, assuming no exercise of the overallotment option. The offering is expected to close on April 9, 2014, subject to customary closing conditions. Ocean Power Technologies Inc (NASDAQ:OPTT), weekly performance is 7.69%. On last trading day company shares ended up $2.94. Ocean Power Technologies Inc (NASDAQ:OPTT), distance from 50-day simple moving average (SMA50) is -23.90%. Analysts mean target Price for the company is $5.00.